FITSUM ALEMU: Open Payments
NPI 1255051306 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 44 payments from 8 companies in 2025. Trend: 2023 $196 · 2024 $566 · 2025 $1,462
Travel & lodging: $867Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $867 |
| ABBVIE INC. | 19 | $195 |
| Otsuka America Pharmaceutical, Inc. | 10 | $151 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
Products named: Deep TMS System, VRAYLAR, REXULTI, COBENFY, UZEDY, TRINTELLIX, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
